Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 15

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 15
---
X CAPEX % rev. CAPEX & Capitalized IT and R&D Investments (in million EUR except %) Change in inventory (324) 165 (157) (631) (411) 26

- 18 - Q4 2024 Results Variations FY24 FY 23 +317 1,462 1,779 EBITDA Adjusted +437 (411) 26 Inventories +27 (61) (34) Receivables - 73 67 (6) Payables +392 (406) (14) Net working capital - 8 (224) (232) CAPEX - 52 (86) (138) IT and R&D - 17 (159) (176) Taxes - 46 (515) (561) Interests +44 (52) (8) Others +629 20 649 Free Cash Flow before extraordinary items - 203 (73) (276) Extraordinary Growth CAPEX +15 (122) (107) Transaction and restructuring costs +442 (176) 266 Free Cash Flow pre - M&A 1 Introductory Remarks Business Performance Financials Final remarks Annex EBITDA Adjusted to Free Cash Flow reconciliation (in million EUR) Note: All figures are presented on a consolidated basis (including Biotest). 1 FCF definition and reconciliation to the Cash Flow Statement in slide 39 in the Annex; 2 FCF conversion = FCF pre - M&A/Adj. EBITDA Free Cash Flow Significant Turnaround in FCF Generation pre - M&A vs. 2023 Strong Results vs. 2023 Strong business momentum and improved EBITDA Inventory management, CPL reduction and yield efficiencies driving FCF generation Considerable improvement in FCF in 2024 vs. 2023 notwithstanding planned extraordinary growth CAPEX spend 1 2 3 1 2 3 15% Free Cash Flow Conversion Rate 2 in FY24

- 19 - Q4 2024 Results Near - term priorities achieved No meaningful funded maturities until Q4 2027 Strengthen liquidity, with total liquidity up to ~€ 1.9bn 1 Considerable 2024 deleveraging (4.6x/2.7x Total/Secured Net Leverage) Credit re - rating progress (million EUR) Sources 1,300 Senior Secured Notes 7.125% due May 2030 43 Cash (million EUR) Uses (343)